Krsnaa Diagnostics Ltd
Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns.[1]
- Market Cap ₹ 1,902 Cr.
- Current Price ₹ 589
- High / Low ₹ 789 / 449
- Stock P/E 36.6
- Book Value ₹ 236
- Dividend Yield 0.47 %
- ROCE 11.9 %
- ROE 8.87 %
- Face Value ₹ 5.00
Pros
- Company has delivered good profit growth of 25.0% CAGR over last 5 years
Cons
- Promoter holding is low: 27.0%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|
36 | 57 | 108 | 147 | 258 | 396 | 455 | 464 | 547 | |
35 | 42 | 169 | 87 | 373 | 302 | 320 | 340 | 423 | |
Operating Profit | 0 | 15 | -62 | 60 | -114 | 94 | 135 | 124 | 123 |
OPM % | 1% | 26% | -57% | 41% | -44% | 24% | 30% | 27% | 23% |
3 | 4 | 3 | 2 | 13 | 265 | 15 | 19 | 18 | |
Interest | 6 | 6 | 8 | 16 | 25 | 26 | 18 | 8 | 11 |
Depreciation | 5 | 10 | 18 | 26 | 32 | 37 | 41 | 54 | 66 |
Profit before tax | -7 | 2 | -84 | 21 | -158 | 295 | 90 | 82 | 64 |
Tax % | -6% | 8% | 29% | 40% | 29% | 37% | 21% | 23% | |
-8 | 2 | -60 | 12 | -112 | 185 | 71 | 64 | 52 | |
EPS in Rs | -15.05 | 4.01 | -116.54 | 24.15 | -216.83 | 284.73 | 22.52 | 20.23 | 16.43 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 11% | 14% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 34% |
3 Years: | 22% |
TTM: | 20% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 25% |
3 Years: | 37% |
TTM: | -27% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 10% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | 9% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|
Equity Capital | 5 | 5 | 5 | 5 | 6 | 16 | 16 | 16 |
Reserves | 4 | 6 | 43 | -217 | -17 | 671 | 727 | 745 |
Preference Capital | 50 | 65 | 141 | 15 | 242 | 0 | 0 | |
81 | 37 | 189 | 231 | 232 | 41 | 32 | 109 | |
74 | 128 | 256 | 611 | 388 | 149 | 134 | 206 | |
Total Liabilities | 163 | 176 | 493 | 630 | 609 | 877 | 909 | 1,075 |
59 | 116 | 223 | 275 | 309 | 386 | 471 | 559 | |
CWIP | 20 | 6 | 42 | 9 | 4 | 28 | 25 | 28 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
85 | 53 | 228 | 345 | 297 | 463 | 413 | 488 | |
Total Assets | 163 | 176 | 493 | 630 | 609 | 877 | 909 | 1,075 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|
59 | 61 | 38 | 119 | 129 | 75 | |||
-53 | -201 | -77 | -67 | -241 | -109 | |||
-37 | 145 | 6 | 20 | 176 | -33 | |||
Net Cash Flow | -31 | 4 | -33 | 71 | 64 | -66 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|
Debtor Days | 87 | 91 | 140 | 87 | 69 | 48 | 59 | |
Inventory Days | 21 | 24 | 89 | |||||
Days Payable | 76 | 99 | 878 | |||||
Cash Conversion Cycle | 32 | 15 | -650 | 87 | 69 | 48 | 59 | |
Working Capital Days | 57 | -43 | -100 | -3 | -23 | -14 | 25 | |
ROCE % | 7% | -65% | 129% | 18% | 12% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
9 Apr - -Analyst / Institutional Investor Meeting scheduled to be held on April 11, 2024.
- Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 ('SEBI Listing Regulations') In Respect Of Incorporation Of A Wholly Owned Subsidiary Company 9 Apr
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
9 Apr - -Analyst / Institutional Investor Meeting scheduled on April 11, 2024.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
9 Apr - -Analyst / Institutional Investor Meeting scheduled to be held on April 10, 2024.
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 6 Apr
Annual reports
Concalls
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Jun 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT REC
-
Jun 2022Transcript PPT
-
Mar 2022TranscriptNotesPPT
-
Feb 2022Transcript PPT
-
Nov 2021TranscriptPPT
-
Oct 2021Transcript PPT
Fastest-growing Diagnostic Center
Krsnaa is one of the fastest-growing diagnostic service providers in the country. [1] Krsnaa has expanded its geographical presence from 50+ centers in FY17 to over 2,000+ centers in FY22. [2] The co. has an extensive network of integrated diagnostic centers across India primarily in non-metro and lower-tier cities and towns. As of FY22, the company-operated diagnostic centers offering radiology and pathology services in 14+ states across India. [3]